Clinical data for normoalbuminuric and microalbuminuric patients (univarate analysis)
| Normoalbuminuric | Microalbuminuric | p Value | |
| n | 909 (90.3%) | 98 (9.7%) | <0.001 |
| Gender | |||
| Male | 471 (51.8%) | 27 (27.5%) | <0.0001 |
| Female | 438 (48.2%) | 71 (72.5%) | |
| Age (years) (median, range) | 13.9 (10.1–20.2) | 14.7 (10.6–19.6) | <0.001 |
| Duration (years) (median, range) | 5.6 (1.1–19.9) | 7.8 (1.7–15.9) | <0.001 |
| Pubertal status | |||
| Prepubertal | 126 (13.9%) | 5 (5.1%) | |
| Pubertal and postpubertal | 782 (86.1%) | 93 (94.9%) | <0.05 |
| HbA1C (%) (geometric mean, range) | 7.15 (3.7–16.8) | 7.76 (4.3–12.5) | 0.001 |
| Insulin dose (unit/kg/24 h) (median, range) | 1.01 (0.17–3.01) | 1.03 (0.58–3.03) | NS |
| Systolic BP (mm Hg) (mean (SD)) | 112.7 (13.1) | 115.6 (14.5) | |
| Standard deviation scores for systolic BP (mean (SD)) | −0.171 (1.070) | 0.023 (1.193) | NS |
| Diastolic BP (mm Hg) (mean (SD)) | 65.7 (11.6) | 67.6 (12.2) | |
| Standard deviation scores for diastolic BP (mean (SD)) | 0.402 (1.17) | 0.572 (1.251) | NS |
| BMI (kg/m2) (mean (SD)) | 21.0 (3.4) | 21.7 (3.7) | |
| Standardised scores for BMI (mean (SD)) | 0.614 (0.955) | 0.581 (1.030) | NS |
| Standardised scores for height (mean (SD)) | 0.034 (1.058) | −0.104 (1.178) | NS |
BP, blood pressure; BMI, body mass index.